click below
click below
Normal Size Small Size show me how
Med Surg Exam 1
| Question | Answer |
|---|---|
| what is the normal lab value for hemoglobin | Male 13.5-18 Female 12-16 |
| what is a main function of sodium in the body | muscle contraction |
| what is a main function of potassium in the body | cardiac conduction |
| describe a stage I pressure ulcer | intact skin w. nonblanchable redness |
| describe stage II pressure ulcer | partial thickness skin loss with pink or red wound bed or blistering |
| describe stage III pressure ulcer | full thickness skin loss with subQ layer showing |
| describe stage IV pressure ulcer | full thickness skin loss with bone or muscle showing |
| normal value for WBC | 4000-11000 |
| normal glucose | 70-110 |
| Lasix; classification and usage | Loop Diuretic; excess fluid volume, HTN, CHF |
| Bumex; class and uses | Loop Diuretic; excess fluid volume, htn, chf |
| Aldactone; class and uses | Potassium sparing diuretic; excess fluid, htn, chf |
| hydrochlorothiazide; class and uses | Thiazide diuretic; excess fluid, htn, chf |
| isotonic IV solution; function and examples | provide balanced electrolytes and water normal saline 0.9% and L.R. solution, D5W |
| hypotonic IV solution; function and examples | provide free water 1/2 NS 0.45% and 1/3 NS 0.33% |
| hypertonic IV solution; function and examples | draw water from interstitial and intracellular space into vascular space D5NS D51/2NS D5LR |
| Zovirax; use | Herpes Simplex |
| Herpes Simplex | fever blisters and cold sores |
| Herpes Zoster | shingles |
| Zostavax; use | herpes zoster |
| neuro disease: tangles and plaques in brain cause neuron damage | AZ |
| autoimmune disorder characterized by neuro disease: demyelinating in the CNS in patches called plaques | MS |
| neuro disease: rapidly progressive degeneration and demyelinating of upper and lower neurons | ALS |
| neuro disease: atrophy of the neurons r/t decreased dopamine production | Parkinson's |
| neuro disease: caused by interrupted blood and oxygen flow to the brain causing brain cell death | CVA |
| neuro disease: autoimmune neuromuscular disorder disease that decreases muscle contractions | myasthenia gravis |
| Cognex; use | AZ treatment |
| Exelon; use | AZ treatment |
| Aricept; use | AZ treatment |
| corticosteroids: Acthar, Delta-sone, Solu-Medrol; use | MS treatment |
| Muscle Relaxants: Lioresal, Dantrium, Valium; use | MS treatment |
| immunosuppressants | MS treatment |
| Rilutrek; use | ALS treatment |
| Levadopa; class and use | dopamine precursor; Parkinson's |
| Symmetrel; class and use | dopamine precursor; Parkinson's |
| Sinemet; class and use | dopamine precursor; Parkinson's |
| Parlodel; class and use | dopamine agonist; Parkinson's |
| Requip; class and use | dopamine agoniost; Parkinson's |
| Plavix; class and use | antiplatelet; CVA |
| Ticlid; class and use | antiplatelet; CVA |
| Persantine; class and use | antiplatelet; CVA |
| Fibrinolytic; use | within 3 hours of CVA |
| myasthenia crisis; define and symptoms | under medicated/ missed doses weakness, vertigo, respiratory crisis |
| cholinergic crisis; define and symptoms | over medicated weakness, vertigo, respiratory crisis |
| Diagnostic procedures for MS | MRI, CT, PET |
| neuro disease: gradual loss of body functions without loss of cognitive function | ALS |
| neuro disease: mask-like faces, trouble starting and stopping motions, excessive sweating | Parkinson's |
| neuro disease: diplopia, dysphagia, muscle weakness | myasthenia gravis |
| Humalog; class, use | rapid-acting insulin, type I diabetes |
| Novolog; class, use | rapid-acting insulin, type 1 diabetes |
| Humulin; class and use | short-acting insulin, type I diabetes |
| NPH; class and use | intermediate-acting insulin; type I diabetes |
| Lantus; class and use | long-acting insulin; type I diabetes |
| Levemir; class and use | long-acting insulin; type I diabetes |
| Glucophage; use | type II diabetes |
| Glucatrol; use | type II diabetes |
| Diabeta; use | type II diabetes |
| Amaryl; use | type II diabetes |
| Avandia; use | type II diabetes |
| Actos; use | type II diabetes |
| a cluster of the most dangerous heart attack risk factors | metabolic syndrome |
| fasting blood glucose: diagnosing diabetes | <126m |
| casual blood glucose: diagnosing diabetes | <200 |
| define primary HTN | caused by pathological processes |
| define secondary HTN | caused by a specific disease process |
| Lotensin; class and uses | ACE inhibitor; HTN, CHF |
| Prinivil; class and uses | ACE inhibitor; HTN, CHF |
| Capoten; class and uses | ACE inhibitor; HTN, CHF |
| vasotec; class and uses | ACE inhibitor; HTN, CHF |
| Avapro; class and uses | ARBS; HTN, CHF |
| Cozaar; class and uses | ARBS; HTN, CHF |
| Cadura; class and use | Alpha Blocker; HTN |
| Minipress; class and use | Alpha Blocker; HTN |
| Hytrin; class and use | Alpha Blocker; HTN |
| Corgard; class and use | Beta Blocker; HTN |
| Tenormin; class and use | Beta Blocker; HTN |
| Inderal; class and use | Beta Blocker; HTN |
| Cardizem; class and use | Calcium blocker; HTN |
| Norvasc; class and use | calcium blocker; HTN |
| Procardia; class and use | calcium blocker; HTN |
| diagnose CHF: jugular distention, increased BP, peripheral edema, weight gain, anorexia | Right-Sided CHF |
| diagnose CHF: cough, lung crackles, SOB, cyanosis, fatigue | Left-Sided CHF |
| CHF that backs fluid up into the body | Right-Sided CHF |
| CHF that backs fluid up into the lungs | Left-sided CHF |
| Digoxin; use | CHF |
| nursing interventions r/t Digoxin | listen to apical pulse for 1 min. prior to med assess cardiac status after med hold is pulse <60bpm monitor for digitalis toxicity |
| digitalis toxicity: symptoms, diagnosing | nausea, vomiting, abdominal pain, weakness, visual changes lab for digoxin levels |